Mesoblast (MESO) Total Debt (2018 - 2025)
Mesoblast's (MESO) quarterly Total Debt came in at -$82.6 million in Q4 2025, down 116.89% year-on-year from $488.8 million in Q4 2024, and down 136.01% quarter-over-quarter from $229.3 million in Q2 2025.
Mesoblast (MESO) Total Debt (2018 - 2025) Analysis & Trends
Mesoblast has disclosed Total Debt across 8 years of filings, most recently posting -$82.6 million for Q4 2025.
- Total Debt for Q4 2025 came in at -$82.6 million, down 116.89% year-over-year; the trailing twelve-month figure through Dec 2025 was -$82.6 million (down 116.89% YoY), and the FY2025 annual result was $229.3 million, up 100.52% from the prior year.
- Total Debt came in at -$82.6 million for Q4 2025 at Mesoblast, down from $229.3 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $229.3 million in Q2 2025 to a low of -$82.6 million in Q4 2025.
- The 5-year median for Total Debt is $86.5 million (2021), against an average of $56.3 million.
- Across the five-year window, Total Debt slumped 141.53% in 2024 and soared 100.52% in 2025, its largest moves.
- Mesoblast's Total Debt stood at $86.5 million in 2021, then tumbled by 121.64% to -$18.7 million in 2022, then increased by 15.85% to -$15.8 million in 2023, then plunged by 141.53% to -$38.1 million in 2024, then slumped by 116.89% to -$82.6 million in 2025.
- The last three Total Debt figures came in at -$82.6 million (Q4 2025), $229.3 million (Q2 2025), and -$38.1 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - | -82.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -82.58 Mn |
| Jun 30, 2025 | 229.29 Mn |
| Dec 31, 2024 | -38.07 Mn |
| Jun 30, 2024 | 114.35 Mn |
| Dec 31, 2023 | -15.76 Mn |
| Jun 30, 2023 | 108.76 Mn |
| Mar 31, 2023 | -20.02 Mn |
| Dec 31, 2022 | -18.73 Mn |
| Sep 30, 2022 | 94.19 Mn |
| Jun 30, 2022 | 96.63 Mn |
| Mar 31, 2022 | 88.65 Mn |
| Dec 31, 2021 | 86.54 Mn |
| Sep 30, 2021 | 53.85 Mn |
| Jun 30, 2021 | 94.25 Mn |
| Mar 31, 2021 | 52.67 Mn |
| Dec 31, 2020 | 49.09 Mn |
| Sep 30, 2020 | 56.10 Mn |
| Jun 30, 2020 | 114.05 Mn |
| Mar 31, 2020 | 59.95 Mn |
| Dec 31, 2019 | 66.00 Mn |